Durability of Response and gender-based analysis from the LINC3 Trial of Osilodrostat in the Treatment in Cushing's Disease
European Society of Endocrinology
9/8/20, 5:00 PM
Europe/Paris GMT+2
Speakers
Rosario Pivonello
Register your event here
Already have an account? LOGIN HERE. If You don't have an account you need to create a free account.